Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRAND PHARMA

8.980
+0.1802.05%
Volume:11.85M
Turnover:106.06M
Market Cap:31.88B
PE:12.74
High:9.080
Open:8.870
Low:8.820
Close:8.800
52wk High:10.200
52wk Low:3.862
Shares:3.55B
HK Float Shares:3.55B
Volume Ratio:0.72
T/O Rate:0.33%
Dividend:0.26
Dividend Rate:2.90%
EPS(LYR):0.705
ROE:12.37%
ROA:4.77%
PB:1.86
PE(LYR):12.74
PS:2.72

Loading ...

GRAND PHARMA (00512) Go Global Strategy Shines at Pujiang Urological Oncology Academic Conference, Nuclear Medicine Drugs Demonstrate Dominant Position, Interim Performance Reaches Record High

Stock News
·
Aug 26

Executive Director Zhou Chao Increases Holdings in GRAND PHARMA (00512) by 45,500 Shares at HK$9.43 per Share

Stock News
·
Aug 25

CICC Maintains Outperform Rating on GRAND PHARMA (00512), Raises Target Price to HK$11.7

Stock News
·
Aug 25

Grand Pharma (00512) Reports Robust Interim Growth with Stock Surging Over 4%, Nuclear Medicine Revenue Doubles to Cement Industry Leadership

Deep News
·
Aug 20

Hong Kong Stock Alert | GRAND PHARMA (00512) Surges Over 4% Following Earnings Release as H1 Revenue Hits Record High, SIR-Spheres Expected to Drive Strong Performance Growth

Deep News
·
Aug 20

Stock Track | Grand Pharma Soars 5.27% Following Strong HY Results and Nuclear Medicine Segment Growth

Stock Track
·
Aug 20

From "China Landing" to "Global Innovation": The Innovation Ecosystem Behind Grand Pharma's (00512) 106% Nuclear Medicine Revenue Surge

Stock News
·
Aug 20

BRIEF-Grand Pharmaceutical Posts HY Profit Attributable HK$1,169.02 Million

Reuters
·
Aug 19

Grand Pharmaceutical's H1 Attributable Profit Slides 25% to HK$1.17 Billion, Revenue Rises 1% to HK$6.11 Billion

MT Newswires Live
·
Aug 19

GRAND PHARMA (00512) Announces 2025 Interim Results: Revenue Hits New High of HK$6.11 Billion, Multiple Innovative Products Drive Volume Growth Showcasing Development Resilience

Stock News
·
Aug 19

Will Weakness in Grand Pharmaceutical Group Limited's (HKG:512) Stock Prove Temporary Given Strong Fundamentals?

Simply Wall St.
·
Aug 08

Grand Pharmaceutical Group Announces Shareholding Restructuring by Controlling Shareholder Group

Reuters
·
Jul 28

BRIEF-Grand Pharmaceutical Says Outwit Investments To Buy 224.4 Million Shares Of Co From East Ocean Capital

Reuters
·
Jul 28

Grand Pharmaceutical - Outwit Investments to Buy 224.4 Mln Shares of Co From East Ocean Capital

THOMSON REUTERS
·
Jul 28

Grand Pharmaceutical Gets Chinese Regulator's Implied Approval for Prostate Cancer Drug to Join Global Study

MT Newswires Live
·
Jul 22

Grand Pharmaceutical Group Ltd. Obtains Implied Approval from NMPA for RDC TLX591 to Join International Phase III Clinical Trial

Reuters
·
Jul 22

With EPS Growth And More, Grand Pharmaceutical Group (HKG:512) Makes An Interesting Case

Simply Wall St.
·
Jul 18

Grand Pharmaceutical Group Ltd. Issues Clarification on Business Collaboration Agreement and Shareholder Status

Reuters
·
Jul 17

Grand Pharmaceutical Group Ltd. Achieves First Batch of Commercial Prescriptions for OC-01 Nasal Spray for Dry Eye Disease Following Official Approval in Mainland China

Reuters
·
Jul 17

Grand Pharma Unit Gets Early US FDA Nod for Liver Cancer Treatment; Shares Gain 3%

MT Newswires Live
·
Jul 08